(Q36599573)

English

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial

scientific article published on 12 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

0 references

5

object named as

Seong-Tae Kim

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

object named as

John C Whittaker

13

0 references

Eugene R Bleecker

17

object named as

Eugene R Bleecker

1 reference

Europe PubMed Central

15 August 2017

PMC publication ID

24

object named as

Jianfeng Xu

1 reference

Europe PubMed Central

15 August 2017

PMC publication ID

William B Isaacs

15

object named as

William B Isaacs

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

21

object named as

S Lilly Zheng

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Aubrey R Turner

10

object named as

Aubrey R Turner

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

object named as

Fang-Chi Hsu

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

2

object named as

Jielin Sun

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

object named as

A Karim Kader

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Roger S Rittmaster

23

object named as

Roger S Rittmaster

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Lynn D Condreay

22

object named as

Lynn D Condreay

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ralph B D'Agostino Jr

7

object named as

Ralph B D'Agostino

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Brian H Reck

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Paul J Newcombe

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sha Tao

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Zheng Zhang

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Greg T Platek

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Colin F Spraggs

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Brian R Lane

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Deborah A Meyers

16

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Frank M Torti

18

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jeffery M Trent

19

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

John D McConnell

20

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

12 May 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

European Urology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

62

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

953-961

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Effect of dutasteride on the risk of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Estimation of absolute risk for prostate cancer using genetic markers and family history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Repeat prostate biopsy--when, where, and how.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Clinical utility of five genetic variants for predicting prostate cancer risk and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Multiple newly identified loci associated with prostate cancer susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Multiple loci identified in a genome-wide association study of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Decision curve analysis: a novel method for evaluating prediction models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

30 September 2017

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

28 June 2018

A common variant associated with prostate cancer in European and African populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

28 June 2018

Genome-wide association studies in cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

20 September 2018

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

20 September 2018

Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3568765

4 December 2018

DD3(PCA3), a very sensitive and specific marker to detect prostate tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22652152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP

1 reference

https://pubmed.ncbi.nlm.nih.gov/22652152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cumulative association of five genetic variants with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22652152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polygenes, risk prediction, and targeted prevention of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22652152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.EURURO.2012.05.006

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36599573&oldid=2098898729"